SEC Tracker
Get the app

Zenas BioPharma ZBIO

Zenas BioPharma announces new stock offering

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Company sold $153.2 million of shares under prior prospectus
  2. Remaining $46.8 million of shares unsold under prior prospectus
  3. Filed new prospectus supplement for up to $200 million in shares

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Zenas BioPharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025
  2. Verastem VSTM public float $254M, Jun 30, 2025
  3. Corvus Pharmaceuticals CRVS public float $252M, Jun 30, 2025
  4. DBV Technologies DBVT public float $251M, Jun 30, 2025
  5. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.